Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
about
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisCathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesvirusesInhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replicationEstablishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomesThe Current State of Vaccine Development for Ocular HSV-1 InfectionSynthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase InhibitorsInhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.Antiviral drug resistance in herpesviruses other than cytomegalovirus.Helicase-primase as a target of new therapies for herpes simplex virus infections.Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools.Bilateral Herpes Simplex Uveitis: Review of the Literature and Own Reports.Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency.Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.Clinical management of herpes simplex virus infections: past, present, and future
P2860
Q24186663-0A550D52-FDF9-4DDA-8D5A-38AC5399CDEAQ33704754-75E45732-E8DC-4B52-B075-66307A4D7A4BQ34165394-705B2D93-18CF-476D-AA6E-FAAA5003011DQ34597590-80F8C9A4-4FCC-4857-A2E2-641810613731Q35168425-A995C84B-E7EC-4B32-8CAE-11536B0F711DQ35559725-EFB391D2-5A1E-4597-9F63-AFBE3FCC1B14Q35606611-BEA6515B-2DD6-451F-A823-EE7BAA3FFDB3Q36730096-415697D1-D7BB-4468-AC72-B7D135F9D3E7Q36760555-381AD276-8FF6-44E2-97E4-EC5E2CAAE61FQ38156730-453F03F9-0D60-4B6D-BBDC-1E141D35512FQ38194111-05009F48-1747-457E-86E9-0FA42E28604DQ38351481-4C4B7A7E-320F-4CE6-9E11-BD07138B2E26Q38770194-FD21F1F4-665C-435F-B7B3-D91A9BC9BCA4Q38785053-AAEF02A9-DB95-4FE9-BC71-1FB08B7DA1FCQ39394174-7FE2BDF0-D7E3-4D3A-8CAE-D14A9951C62AQ42109765-A20DD902-7F46-47CE-859D-FD0E1B758EE0Q47554197-7A0C503D-989E-4A9E-873D-4E90058BA9FFQ59133817-BACBBA98-C486-46BD-A625-D8F609938807
P2860
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@en
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@nl
type
label
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@en
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@nl
prefLabel
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@en
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
@nl
P2093
P2860
P50
P356
P1476
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis
@en
P2093
David A M C van de Vijver
Freek B van Loenen
Lies Remeijer
P2860
P304
P356
10.1093/INFDIS/JIT350
P407
P577
2013-07-30T00:00:00Z